Discovery INI project
In June 2019 Almac Discovery established the Center of Excellence for Ubiquitin Drug Discovery, with the initiative supported by a £5.1M Invest Northern Ireland grant.
The scientific focus is on protein degradation and the new Center will build on the expertise already established around the deubiquitinase (DUB) target class, with a plan to expand into other areas of the ubiquitin-proteasome system as required, across therapeutic indications.
The dedicated Center represents a substantial investment by Almac over a 3 year period, together with support from Invest Northern Ireland via the Grant for R&D Program. This Grant is part-financed by the European Regional Development Fund under the Investment for Growth and Jobs Program 2014-2020.
In July 2018, Almac Discovery and Elasmogen were awarded a grant from Innovate UK through its Innovation in Health and Life Sciences funding program.
The £2M peer reviewed collaborative project entitled ‘A Technology Platform for Next Generation VNAR based Oncology Medicines’, plans to utilize the highly selective, high affinity and yet low molecular weight non-antibody VNAR protein scaffold and build a versatile platform to facilitate the discovery and development of targeted oncology therapeutics.
Innovate UK is the UK’s innovation agency working with people, companies and partner organizations to find and drive science and technology innovations that will grow the UK economy.